Journal:
:international journal of hematology-oncology and stem cell research
0
maryam taghizadeh ghehi research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran.
saeed rezaee department of pharmaceutics, faculty of pharmacy, ahvaz university of medical sciences, ahvaz, iran.
alireza hayatshahi clinical pharmacy department, faculty of pharmacy, tehran university of medical sciences, tehran, iran.
molouk hadjibabaie research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran.
kheirollah gholami research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran.
mohammadreza javadi research center for rational use of drugs, department of clinical pharmacy, faculty of pharmacy, tehran university of medical sciences, tehran, iran.
background: vancomycin is used abundantly in patients undergoing hsct, especially during neutropenic fever. despite its widespread use little is known about vancomycin pharmacokinetics in hsct patients. we conducted this study to investigate vancomycin pharmacokinetic parameters in our hsct patients and to evaluate current dosing regimen based on trough vancomycin concentrations measurement. me...
